These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31118346)

  • 1. The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials.
    Daida H; Dohi T; Fukushima Y; Ohmura H; Miyauchi K
    J Atheroscler Thromb; 2019 Jul; 26(7):592-600. PubMed ID: 31118346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
    Schoenhagen P; Tuzcu EM; Apperson-Hansen C; Wang C; Wolski K; Lin S; Sipahi I; Nicholls SJ; Magyar WA; Loyd A; Churchill T; Crowe T; Nissen SE
    Circulation; 2006 Jun; 113(24):2826-34. PubMed ID: 16769916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology.
    Kovarnik T; Chen Z; Mintz GS; Wahle A; Bayerova K; Kral A; Chval M; Kopriva K; Lopez J; Sonka M; Linhart A
    Cardiovasc Diabetol; 2017 Dec; 16(1):156. PubMed ID: 29212544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update.
    Hartmann M; Huisman J; Böse D; Jensen LO; Schoenhagen P; Mintz GS; Erbel R; von Birgelen C
    Eur J Echocardiogr; 2011 Apr; 12(4):313-21. PubMed ID: 21421584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid profile associated with coronary plaque regression in patients with acute coronary syndrome: Subanalysis of PRECISE-IVUS trial.
    Tsujita K; Yamanaga K; Komura N; Sakamoto K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    Atherosclerosis; 2016 Aug; 251():367-372. PubMed ID: 27318866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Reverse Vessel Remodeling on Regression of Coronary Atherosclerosis in Patients Treated With Aggressive Lipid- and Blood Pressure-Lowering Therapy - Insight From MILLION Study.
    Gamou T; Sakata K; Tada H; Konno T; Hayashi K; Ino H; Yamagishi M; Kawashiri MA;
    Circ J; 2017 Sep; 81(10):1490-1495. PubMed ID: 28515369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lipid-lowering therapy on coronary artery remodeling.
    Schartl M; Bocksch W; Fateh-Moghadam S
    Coron Artery Dis; 2004 Feb; 15(1):45-51. PubMed ID: 15201620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes in Trials Evaluating Lipid-Lowering Drugs.
    Butters J; Brown A; Griffith L; Kim S; Nicholls SJ
    Am J Cardiovasc Drugs; 2017 Dec; 17(6):447-452. PubMed ID: 28432573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.
    Wakabayashi K; Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Miyake S; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Suzuki H; Michishita I;
    J Atheroscler Thromb; 2016 Sep; 23(9):1055-66. PubMed ID: 27040362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plaque burden, microstructures and compositions underachieving very low LDL-C levels.
    Kataoka Y; Andrews J; Puri R; Psaltis PJ; Nicholls SJ
    Curr Opin Endocrinol Diabetes Obes; 2017 Apr; 24(2):122-132. PubMed ID: 28107247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of eicosapentaenoic acid and pitavastatin for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography (CHERRY study)-rationale and design.
    Watanabe T; Miyamoto T; Miyasita T; Shishido T; Arimoto T; Takahashi H; Nishiyama S; Hirono O; Matsui M; Sugawara S; Ikeno E; Miyawaki H; Akira F; Kubota I
    J Cardiol; 2014 Sep; 64(3):236-9. PubMed ID: 24503140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis.
    Girotra S; Murarka S; Migrino RQ
    Panminerva Med; 2012 Jun; 54(2):71-81. PubMed ID: 22525562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular ultrasound for the evaluation of therapies targeting coronary atherosclerosis.
    Böse D; von Birgelen C; Erbel R
    J Am Coll Cardiol; 2007 Mar; 49(9):925-32. PubMed ID: 17336714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.
    Räber L; Taniwaki M; Zaugg S; Kelbæk H; Roffi M; Holmvang L; Noble S; Pedrazzini G; Moschovitis A; Lüscher TF; Matter CM; Serruys PW; Jüni P; Garcia-Garcia HM; Windecker S;
    Eur Heart J; 2015 Feb; 36(8):490-500. PubMed ID: 25182248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary atherosclerotic plaque progression: contributing factors in statin-treated patients.
    Clark D; Puri R; Nissen SE
    Expert Rev Cardiovasc Ther; 2020 Dec; 18(12):873-880. PubMed ID: 33048622
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of lipid-lowering therapy with pitavastatin, a new HMG-CoA reductase inhibitor, on regression of coronary atherosclerotic plaque.
    Takashima H; Ozaki Y; Yasukawa T; Waseda K; Asai K; Wakita Y; Kuroda Y; Kosaka T; Kuhara Y; Ito T
    Circ J; 2007 Nov; 71(11):1678-84. PubMed ID: 17965484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
    Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Circ J; 2011; 75(2):398-406. PubMed ID: 21157106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.